Platform Trial to Assess the Efficacy of Multiple Drugs in Amyotrophic Lateral Sclerosis (ALS)

NCT06008249 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
88
Enrollment
OTHER
Sponsor class

Stopped The planned interim analysis showed no survival benefit of taking the drug when compared with placebo.

Conditions

Interventions

Sponsor

Stichting TRICALS Foundation

Collaborators